Search Results

Novel Targeted Radiosensitisers in Cancer Treatment

Authors: Zaidi, Shane H.; Huddart, Robert A.; Harrington, Kevin J.

Source: Current Drug Discovery Technologies, Volume 6, Number 2, June 2009 , pp. 103-134(32)

Publisher: Bentham Science Publishers

The ATM regulated DNA damage response pathway as a chemo- and radiosensitisation target

Author: Alao, John P

Source: Expert Opinion on Drug Discovery, Volume 4, Number 5, May 2009 , pp. 495-505(11)

Publisher: Informa Healthcare

Radiosensitising agents for the radiotherapy of cancer: advances in traditional and hypoxia targeted radiosensitisers

Authors: Bischoff, Pierre; Altmeyer, Anais; Dumont, Francis

Source: Expert Opinion on Therapeutic Patents, Volume 19, Number 5, May 2009 , pp. 643-662(20)

Publisher: Informa Healthcare

Probing the interactions of the solvated electron with DNA by molecular dynamics simulations: II. bromodeoxyuridine-thymidine mismatched DNA

Authors: Gantchev, Tsvetan; Hunting, Darel

Source: Journal of Molecular Modeling, Volume 15, Number 1, January 2009 , pp. 9-23(15)

Publisher: Springer

Therapeutic potential of drugs to modulate DNA repair in cancer

Author: Curtin, Nicola

Source: Expert Opinion on Therapeutic Targets, Volume 11, Number 6, June 2007 , pp. 783-799(17)

Publisher: Informa Healthcare

Samarium for osteoblastic bone metastases and osteosarcoma

Author: Anderson, Pete

Source: Expert Opinion on Pharmacotherapy, Volume 7, Number 11, August 2006 , pp. 1475-1486(12)

Publisher: Informa Healthcare

Enhancement of effects of irradiation by gemcitabine in a glioblastoma cell line and cell line spheroids

Authors: Genç, Mine; Castro Kreder, Natasja; Barten-van Rijbroek, Angelique; Stalpers, Lukas; Haveman, Jaap

Source: Journal of Cancer Research and Clinical Oncology, Volume 130, Number 1, January 2004 , pp. 45-51(7)

Publisher: Springer

Gene therapy strategies to improve the effectiveness of cancer radiotherapy

Authors: Svend O Freytag; Jae Ho Kim; Stephen L Brown; Kenneth Barton; Mei Lu; Myung Chung

Source: Expert Opinion on Biological Therapy, Volume 4, Number 11, 1 November 2004 , pp. 1757-1770(14)

Publisher: Informa Healthcare

Membrane Targeted Anticancer Drugs: Potent Inducers of Apoptosis and Putative Radiosensitisers

Authors: Jendrossek V.; Handrick R.

Source: Current Medicinal Chemistry - Anti-Cancer Agents, Volume 3, Number 5, September 2003 , pp. 343-353(11)

Publisher: Bentham Science Publishers

The radiosensitising effect of gemcitabine and the influence of the rescue agent amifostine in vitro

Authors: Pauwels B.; Korst A.E.C.; de Pooter C.M.J.; Lambrechts H.A.J.; Pattyn G.G.O.; Lardon F.; Vermorken J.B.

Source: European Journal of Cancer, Volume 39, Number 6, April 2003 , pp. 838-846(9)

Publisher: Elsevier

Radiosensitisation of cultured cells by brostallicin - a brominated minor groove binding DNA ligand

Source: European Journal of Cancer, Volume 38, Supplement 7, November 2002 , pp. 27-27(1)

Publisher: Elsevier

Back to baked potato? Or is it another “laboratory finding”?

Source: Annals of Oncology, Volume 13, Number 8, August 2002 , pp. 1163-1164(2)

Publisher: Oxford University Press

Advanced pancreatic cancer—5 years on

Authors: S. Rao; D. Cunningham

Source: Annals of Oncology, Volume 13, Number 8, August 2002 , pp. 1165-1168(4)

Publisher: Oxford University Press

Cyclooxygenase-2 (COX-2) a new prognostic and predictive factor for ovarian cancer? Are all the criteria fulfilled?

Authors: M. Castiglione; L. Nasi

Source: Annals of Oncology, Volume 13, Number 8, August 2002 , pp. 1169-1171(3)

Publisher: Oxford University Press

Heating the patient: a promising approach?

Author: J. van der Zee

Source: Annals of Oncology, Volume 13, Number 8, August 2002 , pp. 1173-1184(12)

Publisher: Oxford University Press

Reply to “Adjuvant interferon for melanoma”, by K. Wheatley & N. Ives

Authors: C.J.A. Punt; A.M.M. Eggermont

Source: Annals of Oncology, Volume 13, Number 8, August 2002 , pp. 1320-1320(1)

Publisher: Oxford University Press

Reply: Prediction of survival in terminally ill cancer patients: the reasons why we cannot avoid an evidence-based palliative medicine

Authors: D. Tassinari; M. Maltoni; D. Amadori

Source: Annals of Oncology, Volume 13, Number 8, August 2002 , pp. 1322-1323(2)

Publisher: Oxford University Press

Mathematical modelling for the new millenium: medicine by numbers

Authors: Smye S.W.; Clayton R.H.

Source: Medical Engineering and Physics, Volume 24, Number 9, November 2002 , pp. 565-574(10)

Publisher: Elsevier

Biological basis for chemo-radiotherapy interactions

Authors: Hennequin C.; Favaudon V.

Source: European Journal of Cancer, Volume 38, Number 2, 2002 , pp. 223-230(8)

Publisher: Elsevier

The relationship between Fludarabine-induced radiosensitisation and apoptosis in six human squamous cell carcinoma lines

Authors: Pradier O.; Rave-Fraenk M.; Lucke E.; Peters K.; Schmidberger H.; Hille A.; Hess C.

Source: European Journal of Cancer, Volume 37, Supplement 6, April 2001 , pp. 206-206(1)

Publisher: Elsevier